Jean Frédéric Blanc

机构：Sciences Po Bordeaux, Université de Bordeaux, Centre Hospitalier Universitaire de Bordeaux, Hôpital Cardiologique du Haut-Lévêque, Institut Polytechnique de Bordeaux · ORCID：0000-0001-6172-9485

发表论文 44 篇 · 总被引 20442 次 · h-index 19

代表论文

• Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial (2023 · The Lancet · 被引 531)
• PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases (2018 · International Journal of Cancer · 被引 136)
• A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease (2019 · Hepatology · 被引 105)
• Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study. (2021 · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · 被引 75)
• Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma (2021 · Liver Cancer · 被引 53)
• Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI) (2021 · Clinics and Research in Hepatology and Gastroenterology · 被引 32)